EUVIMEDEUVIMED entdecken
Querschnittstudie

Serum Fructosamine and HbA1c as Complementary Glycemic Control Biomarkers in Type 2 Diabetes: A Cross-Sectional Diagnostic Accuracy Study from India

Thejdeep Mahamkali, C Arul Murugan

International Journal of Drug Delivery Technology · 25.05.2026 · 16 (36s)

DOI: 10.25258/ijddt.16.36s.36 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift International Journal of Drug Delivery Technology, erschienen am 25.05.2026. Verfasst von Thejdeep Mahamkali und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hemoglobin A1c (HbA1c) is the gold standard for assessing long-term glycemic control, but its 3- month averaging window limits detection of recent metabolic changes. Serum fructosamine, reflecting 2–3 week glucose exposure, could serve as a complementary surveillance marker. The relationship between these markers remains incompletely characterized, particularly in Indian diabetes populations.

Objective

To evaluate whether serum fructosamine and HbA1c function as interchangeable or complementary glycemic control biomarkers, and to determine the diagnostic accuracy of fructosamine for identifying poor glycemic control.

Methods

A cross-sectional comparative study enrolled 100 patients with Type 2 diabetes at a tertiary care teaching institution in India. Fasting blood samples were analyzed for HbA1c (using high-performance liquid chromatography), serum fructosamine (nitroblue tetrazolium colorimetric method), glucose measurements, and renal function. Pearson and Spearman correlations quantified biomarker relationships. Categorical agreement was assessed using Cohen's kappa. Receiver operating characteristic (ROC) curve analysis determined diagnostic performance.

Results

The study included 100 participants (60% male, mean age 60.5 ± 7.6 years). Fructosamine and HbA1c demonstrated strong positive correlation (r = 0.673, 95% CI: 0.551–0.770, p < 0.001), with R² = 0.452 indicating 45.2% shared variance. However, categorical agreement was fair (κ = 0.315), with 39% discordance: fructosamine classified 62% as poor control versus 48% by HbA1c (p < 0.001). For detecting poor control (HbA1c >8%), raw fructosamine at 340 µmol/L achieved excellent discrimination (AUC = 0.846, 95% CI: 0.749–0.926) with sensitivity 89.6%, specificity 56.9%, and negative predictive value 85.3%. Albumin-corrected fructosamine performed worse (AUC 0.783). Serum albumin-fructosamine correlation was weak (r = -0.149), and 99% of participants had preserved renal function (CKD stage G1).

Conclusions

Serum fructosamine and HbA1c demonstrate strong correlation but substantial categorical discordance, establishing them as complementary rather than interchangeable glycemic biomarkers. Fructosamine's shorter measurement window (2–3 weeks) and high sensitivity (89.6%) for poor control detection position this marker as a valuable surveillance tool for detecting recent glycemic deterioration between routine HbA1c measurements. In populations with preserved renal function and normal albumin levels, raw (uncorrected) fructosamine should be used. These findings support incorporating fructosamine into comprehensive diabetes monitoring protocols as a complementary biomarker to improve early detection of glycemic decompensation and facilitate more responsive treatment adjustment in high-risk populations.

Zitieren

APA

Mahamkali, T., & Murugan, C. A. (2026). Serum Fructosamine and HbA1c as Complementary Glycemic Control Biomarkers in Type 2 Diabetes: A Cross-Sectional Diagnostic Accuracy Study from India. International Journal of Drug Delivery Technology, 16(36s). https://doi.org/10.25258/ijddt.16.36s.36

Vancouver

Mahamkali T, Murugan CA. Serum Fructosamine and HbA1c as Complementary Glycemic Control Biomarkers in Type 2 Diabetes: A Cross-Sectional Diagnostic Accuracy Study from India. International Journal of Drug Delivery Technology. 2026;16(36s). doi:10.25258/ijddt.16.36s.36

BibTeX
@article{Mahamkali2026,
  author = {Mahamkali, Thejdeep and Murugan, C Arul},
  title = {Serum Fructosamine and HbA1c as Complementary Glycemic Control Biomarkers in Type 2 Diabetes: A Cross-Sectional Diagnostic Accuracy Study from India},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {36s},
  doi = {10.25258/ijddt.16.36s.36}
}
Kostenlos starten →